---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-273579"
form_type: "8-K"
ticker: "BIIB"
cik: "0000875045"
company_name: "BIOGEN INC."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T12:22:06.005370+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Biogen elects Monish Patolawala to board effective Jan 1, 2024

## Summary
- Monish Patolawala elected as director to fill a vacancy; term expires at 2024 Annual Meeting.
- Patolawala qualifies as an audit committee financial expert; expected to join Audit Committee.
- He will enter into standard indemnification agreement with Biogen.

## SEC filing metadata
- accession: 0001193125-23-273579
- form_type: 8-K
- ticker: BIIB
- cik: 0000875045
- company_name: BIOGEN INC.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875045/000119312523273579/0001193125-23-273579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875045/000119312523273579/d454419d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-273579
- JSON: https://secwatch.observer/filing/0001193125-23-273579.json
- Plain text: https://secwatch.observer/filing/0001193125-23-273579.txt

## Key facts
- Executive change
  Monish Patolawala was elected as Director at BIOGEN INC..
  - Action: elected
  - Role: Director
  source text: On November 6, 2023, the Board of Directors (the “Board”) of Biogen Inc. (the “Company”) elected Monish Patolawala as a director (term to expire at the 2024 Annual Meeting) to fill a vacancy, effective January 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/875045/000119312523273579/0001193125-23-273579-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.